anonymous
Guest
anonymous
Guest
Just announced....... It looks like a company named Lupin will be getting FDA approval to market a generic diclofenac capsule at 18 and 35 mg doses.
Provide a link - nothing on their website.
Just announced....... It looks like a company named Lupin will be getting FDA approval to market a generic diclofenac capsule at 18 and 35 mg doses.
Provide a link - nothing on their website.
If you haven't already been shopping around a polished resume, you are extinct.https://www.google.com/amp/m.econom...on/amp_articleshow/55831926.cms?client=safari
Not good at all, get those resumes ready.
Lupin gets USFDA nod for Diclofenac capsules' generic version - The Economic Times on Mobile
http://m.economictimes.com/industry...ules-generic-version/articleshow/55831926.cms
Do you think the president of Lupin likes Star Trek or Star Wars? Looks like Iroko got outsmarted. Goes to show that there is zero value to SoluMatrix technology.
Do you think the president of Lupin likes Star Trek or Star Wars? Looks like Iroko got outsmarted. Goes to show that there is zero value to SoluMatrix technology.
Do you think the president of Lupin likes Star Trek or Star Wars? Looks like Iroko got outsmarted. Goes to show that there is zero value to SoluMatrix technology.
well, Lupin will sometimes get approval for generic drugs and then just sit on it until the day comes where they can sell the generic. They will sit on it for years if needed. Not to mention, iroko can fight it in the courts if there is some type of infringement. Just hang tight.
well, Lupin will sometimes get approval for generic drugs and then just sit on it until the day comes where they can sell the generic. They will sit on it for years if needed. Not to mention, iroko can fight it in the courts if there is some type of infringement. Just hang tight.
Great! Now we are paying lawyers to sue!
There goes our retention bonus!
Nobody will buy or invest in these products with generic threat on the horizon next year.
You read it there. Iroko admits generic entry mid 2017